Alzheimer’s disease and gut microbiota
Open accessThe DOI matches its Crossref record; 195 of the 196 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a most common neurodegenerative disorder, which associates with impaired cognition. Gut microbiota can modulate host brain function and behavior via microbiota-gut-brain axis, including cognitive behavior. Germ-free animals, antibiotics, probiotics intervention and diet can induce alterations of gut microbiota and gut physiology and also host cognitive behavior, increasing or decreasing risks of AD. The increased permeability of intestine and blood-brain barrier induced by gut microbiota disturbance will increase the incidence of neurodegeneration disorders. Gut microbial metabolites and their effects on host neurochemical changes may increase or decrease the risk of AD. Pathogenic microbes infection will also increase the risk of AD, and meanwhile, the onset of AD support the "hygiene hypothesis". All the results suggest that AD may begin in the gut, and is closely related to the imbalance of gut microbiota. Modulation of gut microbiota through personalized diet or beneficial microbiota intervention will probably become a new treatment for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The microbiota-gut-brain axis refers to a bidirectional communication system between the gut and the brain, including metabolic, endocrine, neural, and immune pathways that can work independently or in concert.213,216”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [216]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Hay fever, hygiene, and household size.
Strachan, D. P. (1989) · BMJ · doi:10.1136/bmj.299.6710.1259 · Cited by 5,054
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
Research works printed but not linked: 1
- Pautas, E., Cherin, P., De Jaeger, C., and Godeau, P. (1999). Vitamin B12 deficiency in the elderly. Presse Med 28, 1767-1770.
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“216 The microbiota-gut-brain axis refers to a bidirectional communication system between the gut and the brain, including metabolic, endocrine, neural, and immune pathways that can work independently or in concert.”
BackgroundRoles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
Zhuang, Z.-Q., Shen, L.-L., Li, W.-W., Fu, X., Zeng, F., Gui, L., Lü, Y., Cai, M., Zhu, C., Tan, Y.-L., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180176 · Cited by 885
“Gut microbiota play important roles in the synthesis of brain neurotransmitters such as (cid:6) -aminobutyric acid (GABA), serotonin, and brain-derived neurotrophic factor which are all related with AD [37].”
Gut microbiota: A player in aging and a target for anti-aging intervention
Vaiserman, A. M., Koliada, A. K., & Marotta, F. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.01.001 · Cited by 465
Antibiotics, gut microbiota, and Alzheimer’s disease
Angelucci, F., Cechova, K., Amlerova, J., & Hort, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1494-4 · Cited by 454
Fecal Microbiota Transplantation in Neurological Disorders
Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Contarino, M. F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00098 · Cited by 413
Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice
Yang, X., Yu, D., Xue, L., Li, H., & Du, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.07.001 · Cited by 407
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
Qian, Y., Yang, X., Xu, S., Wu, C., Song, Y., Qin, N., Chen, S.-D., & Xiao, Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.016 · Cited by 409
(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease
Buford, T. W. (2017) · Microbiome · doi:10.1186/s40168-017-0296-0 · Cited by 409
“The leaky gut is well-associated with inflammatory bowel conditions but is now being proposed as a contributor to a wide variety of health conditions [87, 88]—with particular interest in a gut-brain axis which regulates the blood brain barrier [61, 62, 75, 76].”
Li, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406
Self-citationZhao, Y., Jaber, V., & Lukiw, W. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00318 · Cited by 379
“Together with host cells these jointly comprise the complete metaorganism: (i) whose symbiotic associations and interactions are indispensable for homeostatic physiological functions in human health; and (ii) which exhibit alterations in composition in response to dietary factors, developmental stage, GI tract disturb…”
BackgroundInfluentialGubert, C., Kong, G., Renoir, T., & Hannan, A. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104621 · Cited by 363
The integration of inflammaging in age-related diseases
Fulop, T., Witkowski, J. M., Olivieri, F., & Larbi, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.003 · Cited by 348
Gut microbiota in neurodegenerative disorders
Roy Sarkar, S., & Banerjee, S. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.01.004 · Cited by 314
The microbiota-gut-brain axis in sleep disorders
Wang, Z., Wang, Z., Lu, T., Chen, W., Yan, W., Yuan, K., Shi, L., Liu, X., Zhou, X., Shi, J., et al. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101691 · Cited by 285
“At the same time, alteration of bacterial fl ora can also occur in AD [80].”
Pellegrini, C., Antonioli, L., Colucci, R., Blandizzi, C., & Fornai, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1856-5 · Cited by 270
“Increasing evidence supports the contention that alterations of enteric bacteria-neuro-immune network may contribute to the pathogenesis of AD [45, 46, 106].”
BackgroundUnhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266
“Investigations utilizing GF mice, as well as mice treated with probiotics or antibiotics, indicate that, in addition to impacting the molecular hallmarks of AD, bacteria have an important role in regulating learning, memory, and cognition (Hu et al., 2016).”
Gut-Brain Psychology: Rethinking Psychology From the Microbiota–Gut–Brain Axis
Liang, S., Wu, X., & Jin, F. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00033 · Cited by 263
“, 2017), while microbiota interventions, such as probiotic supplementation, may prevent or even reverse this process (Hu et al., 2016; Westfall et al., 2017).”
BackgroundInfluentialSelf-citationPistollato, F., Iglesias, R. C., Ruiz, R., Aparicio, S., Crespo, J., Lopez, L. D., Manna, P. P., Giampieri, F., & Battino, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.012 · Cited by 247
Agahi, A., Hamidi, G. A., Daneshvar, R., Hamdieh, M., Soheili, M., Alinaghipour, A., Esmaeili Taba, S. M., & Salami, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00662 · Cited by 247
“Therefore, intervenes like antibiotics, probiotics, pathogens, and nutrition are expected to affect the composition of gut microbiota and physiological function of gut and, thus, influence the host cognitive behavior and change the risk of AD (36).”
BackgroundMancuso, C., & Santangelo, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.009 · Cited by 232
“Honestly speaking, the role of dysbiosis, as a risk factor for AD, has been suggested mainly on the basis of preclinical studies carried out in rodent models of AD, germ-free animals, etc [93]; only a few clinical trials are currently available supporting this supposition [93].”
BackgroundThe critical role of Faecalibacterium prausnitzii in human health: An overview
Leylabadlo, H. E., Ghotaslou, R., Feizabadi, M. M., Farajnia, S., Moaddab, S. Y., Ganbarov, K., Khodadadi, E., Tanomand, A., Sheykhsaran, E., Yousefi, B., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104344 · Cited by 229
Chen, D., Yang, X., Yang, J., Lai, G., Yong, T., Tang, X., Shuai, O., Zhou, G., Xie, Y., & Wu, Q. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00403 · Cited by 227
“The modulation of gut microbiota by germ-free animals, probiotics or antibiotics intervention, and fecal microbiota transplantation (FMT) can influence the cognitive behavior of the host (Hu et al., 2016).”
The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., et al. (2022) · Nutrients · doi:10.3390/nu14030668 · Cited by 225
“The role of gut microbiota and GMBA in AD is of utmost importance [34].”
BackgroundChen, C., Ahn, E. H., Kang, S. S., Liu, X., Alam, A., & Ye, K. (2020) · Science Advances · doi:10.1126/sciadv.aba0466 · Cited by 205
“GF (germ-free) animals, antibiotics interference, probiotics intervention, pathogen infection, and dietary habits not only affect the composition of gut microbiota and physiological function of the gut but also impinge on host cognitive behavior and alter the risk of AD (2).”
BackgroundSundman, M. H., Chen, N.-K., Subbian, V., & Chou, Y.-H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.05.009 · Cited by 199
Kabir, M. T., Rahman, M. H., Shah, M., Jamiruddin, M. R., Basak, D., Al-Harrasi, A., Bhatia, S., Ashraf, G. M., Najda, A., El-kott, A. F., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112610 · Cited by 181
Zeolite Clinoptilolite: Therapeutic Virtues of an Ancient Mineral
Mastinu, A., Kumar, A., Maccarinelli, G., Bonini, S. A., Premoli, M., Aria, F., Gianoncelli, A., & Memo, M. (2019) · Molecules · doi:10.3390/molecules24081517 · Cited by 180
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177
Impact of plant extracts upon human health: A review
Veiga, M., Costa, E. M., Silva, S., & Pintado, M. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1540969 · Cited by 174
“…microbiota has been studied as a possible alternative to current treatments used, with plant extracts being a focal point due to their constitution (Hu, Wang, and Jin 2016, Morais et al. 2016, CONTACT Manuela Pintado mpintado@porto.ucp.pt CBQF – Centro de Biotecnologia e Qu ımica Fina – Laborat…”
BackgroundCircadian and sleep dysfunction in Alzheimer’s disease
Uddin, M. S., Tewari, D., Mamun, A. A., Kabir, M. T., Niaz, K., Wahed, M. I. I., Barreto, G. E., & Ashraf, G. M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101046 · Cited by 173
Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder
Bastiaanssen, T. F. S., Cussotto, S., Claesson, M. J., Clarke, G., Dinan, T. G., & Cryan, J. F. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000243 · Cited by 159
Role of the peripheral innate immune system in the development of Alzheimer's disease
Le Page, A., Dupuis, G., Frost, E. H., Larbi, A., Pawelec, G., Witkowski, J. M., & Fulop, T. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.019 · Cited by 157
Xie, J., Cools, L., Van Imschoot, G., Van Wonterghem, E., Pauwels, M. J., Vlaeminck, I., De Witte, C., EL Andaloussi, S., Wierda, K., De Groef, L., et al. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12306 · Cited by 149
“Growing evidence supports the concept that the gut microbiota affects host brain function including cognitive behaviour and that a microbiota dysbiosis may mediate or affect AD pathogenesis (Hu et al., 2016).”
BackgroundRezaei Asl, Z., Sepehri, G., & Salami, M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112183 · Cited by 149
Raimondi, I., Izzo, L., Tunesi, M., Comar, M., Albani, D., & Giordano, C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00435 · Cited by 156
Relevance of gutmicrobiota in cognition, behaviour and Alzheimer’s disease
de J.R. De-Paula, V., Forlenza, A. S., & Forlenza, O. V. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.007 · Cited by 145
The Contribution of Gut Microbiota–Brain Axis in the Development of Brain Disorders
Maiuolo, J., Gliozzi, M., Musolino, V., Carresi, C., Scarano, F., Nucera, S., Scicchitano, M., Oppedisano, F., Bosco, F., Ruga, S., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.616883 · Cited by 164
“Several studies in recent years have been carried out and have highlighted the involvement of the intestinal microbiota in the onset and pathophysiology of AD (Hu et al., 2016; Jiang et al., 2017).”
BackgroundBarrio, C., Arias-Sánchez, S., & Martín-Monzón, I. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105640 · Cited by 143
Guan, Z., Jin, X., Guan, Z., Liu, S., Tao, K., & Luo, L. (2023) · Aging Cell · doi:10.1111/acel.13807 · Cited by 141
Fujii, Y., Nguyen, T. T. T., Fujimura, Y., Kameya, N., Nakamura, S., Arakawa, K., & Morita, H. (2019) · Bioscience, Biotechnology, and Biochemistry · doi:10.1080/09168451.2019.1644149 · Cited by 132
“disease [16], a progressive degenerative disorder of the central nervous system that impairs cognition, presumably via a microbiota-gut-brain axis, which appears to be essential to health.”
BackgroundThe Relationship Between the Gut Microbiome and Neurodegenerative Diseases
Zhu, X., Li, B., Lou, P., Dai, T., Chen, Y., Zhuge, A., Yuan, Y., & Li, L. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00730-8 · Cited by 130
“A large number of studies have linked intestinal microbiome disorders to a variety of diseases, including inflammatory bowel disease (Crohn’s disease [1], irritable bowel syndrome [2], and colon cancer [3]), neurological diseases (Alzheimer’s disease (AD) [4], and Parkinson’s disease (PD) [5]), metabolic diseases (dia…”
BackgroundBacteroidetes Neurotoxins and Inflammatory Neurodegeneration
Zhao, Y., & Lukiw, W. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1015-y · Cited by 145
Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut Microbiome
Hoffman, J. D., Parikh, I., Green, S. J., Chlipala, G., Mohney, R. P., Keaton, M., Bauer, B., Hartz, A. M. S., & Lin, A.-L. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00298 · Cited by 122
Outer membrane vesicles enhance tau phosphorylation and contribute to cognitive impairment
Wei, S., Peng, W., Mai, Y., Li, K., Wei, W., Hu, L., Zhu, S., Zhou, H., Jie, W., Wei, Z., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29362 · Cited by 120
AlAmmar, W. A., Albeesh, F. H., Ibrahim, L. M., Algindan, Y. Y., Yamani, L. Z., & Khattab, R. Y. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1659560 · Cited by 116
Circadian Rhythm and Alzheimer’s Disease
Homolak, J., Mudrovčić, M., Vukić, B., & Toljan, K. (2018) · Medical Sciences · doi:10.3390/medsci6030052 · Cited by 140
“The latter is currently a topic of special interest in studies focusing on microbiota-gut-brain axis interactions in AD [52,80,81].”
BackgroundThe Mechanism of Acrylamide-Induced Neurotoxicity: Current Status and Future Perspectives
Zhao, M., Zhang, B., & Deng, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.859189 · Cited by 135
Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress?
Sharma, V., Singh, T. G., Garg, N., Dhiman, S., Gupta, S., Rahman, M. H., Najda, A., Walasek-Janusz, M., Kamel, M. S., Albadrani, G. M., et al. (2021) · Biomolecules · doi:10.3390/biom11050678 · Cited by 117
“These inflammatory changes induce endotoxemia-mediated systemic inflammation, while restricted calorie intake optimizes gut microbiota composition and diversity [58].”
BackgroundInfluentialArora, K., Green, M., & Prakash, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.537847 · Cited by 108
“(GF) mice display a decrease in tight junction (TJ) protein levels, accompanied by clear deficiencies in non-spatial and memory-based exercises, as well as a reduced level of BDNF and a decreased expression of N-methyl-D-aspartate receptor (NMDAr) mRNA in the hippocampal and cortex regions (Hu et al., 2016).”
BackgroundChen, X., Xu, L., Chen, Q., Su, S., Zhuang, J., & Qiao, D. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115000 · Cited by 127
Identifying modifiable factors and their joint effect on dementia risk in the UK Biobank
Zhang, Y., Chen, S.-D., Deng, Y., You, J., He, X., Wu, X., Wu, B., Liu, Y., Zhang, Y.-R., Kuo, K., et al. (2023) · Nature Human Behaviour · doi:10.1038/s41562-023-01585-x · Cited by 117
“383) Hand grip strength (35,85) Hand grip strength (25,35) Basal metabolic rate (7.”
BackgroundXin, Y., Diling, C., Jian, Y., Ting, L., Guoyan, H., Hualun, L., Xiaocui, T., Guoxiao, L., Ou, S., Chaoqun, Z., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00412 · Cited by 104
“Mechanisms that regulate the GIT microbes have recently been shown to regulate cognition in the host, regardless of whether animals without germs, animals treated with antibiotics or probiotics administration or animals receiving a fecal microbial transplant (FMT) were used (40).”
MethodDietary nutrition and gut microflora: A promising target for treating diseases
Nie, Y., Luo, F., & Lin, Q. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.03.002 · Cited by 112
Impact of gut microbiota on neurological diseases: Diet composition and novel treatments
Larroya-García, A., Navas-Carrillo, D., & Orenes-Piñero, E. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1484340 · Cited by 99
Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
Colognesi, M., Gabbia, D., & De Martin, S. (2020) · Biomedicines · doi:10.3390/biomedicines8070229 · Cited by 98
“suggested three putative groups of genes involved in both AD and NAFLD related to carbohydrate metabolism, long fatty acid metabolism, and interleukin signaling pathways [37].”
BackgroundBorrego-Ruiz, A., & Borrego, J. J. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110861 · Cited by 122
“…induces the secretion of LPS, which disrupts gastrointestinal permeability and the blood-brain barrier (BBB), modulating the inflammatory pathway that promotes neuroinflammation and cognitive decline, and leads to neuronal death in AD (Hu et al., 2016; Kesika et al., 2021; Varesi et al., 2022).”
Singh, A., Vishwakarma, V., & Singhal, B. (2018) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2018.94012 · Cited by 101
“tangles (NFT) has been recognized as the major factors for contributing the disease development [110] [111].”
BackgroundYe, M., Yu, J., Shi, X., Zhu, J., Gao, X., & Liu, W. Y. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1803198 · Cited by 102
Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases
Konjevod, M., Perković, M. N., Sáiz, J., Štrac, D. Š., Barbas, C., & Rojo, D. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113681 · Cited by 106
The Gut-Brain Axis in Alzheimer’s Disease and Omega-3. A Critical Overview of Clinical Trials
La Rosa, F., Clerici, M., Ratto, D., Occhinegro, A., Licito, A., Romeo, M., Iorio, C. D., & Rossi, P. (2018) · Nutrients · doi:10.3390/nu10091267 · Cited by 93
“Increasing clinical findings [13,14] reveal that the pathogenesis of many neurodegenerative diseases may depend on the gut microbiota and that the resident commensal microbiota modulates CNS autoimmunity [43,44], beyond neuroinflammation [45,46].”
BackgroundProbiotics and prebiotics: focus on psychiatric disorders – a systematic review
Barbosa, R. S. D., & Vieira-Coelho, M. A. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz080 · Cited by 93
Gut microbiota and central nervous system development
Principi, N., & Esposito, S. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.09.010 · Cited by 92
Research Progress on Alzheimer's Disease and Resveratrol
Yan, Y., Yang, H., Xie, Y., Ding, Y., Kong, D., & Yu, H. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03007-0 · Cited by 98
Austad, S. N., Ballinger, S. W., Buford, T. W., Carter, C. S., Smith, D. L., Darley-Usmar, V. M., & Zhang, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.014 · Cited by 100
Human Gut Microbiota in Health and Alzheimer’s Disease
Szablewski, L. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170908 · Cited by 91
“Therefore, the risk of AD may depend on the number of Cyanobacteria in human intestine [117].”
Song, X., Zhao, Z., Zhao, Y., Wang, Z., Wang, C., Yang, G., & Li, S. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1991556 · Cited by 81
“function and behavior via the gut-brain axis [7].”
BackgroundSu, A., Yang, W., Zhao, L., Pei, F., Yuan, B., Zhong, L., Ma, G., & Hu, Q. (2018) · Food & Function · doi:10.1039/c7fo01991b · Cited by 87
Wu, M.-L., Yang, X.-Q., Xue, L., Duan, W., & Du, J.-R. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113125 · Cited by 79
Yadav, E., Yadav, P. S., Khan, M. M. U., Singh, H., & Verma, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.922232 · Cited by 93
“different damaging effects and can act as a SIRT1 agonist (Hu et al., 2016; Yan et al., 2020).”
BackgroundCogliati, S., Clementi, V., Francisco, M., Crespo, C., Argañaraz, F., & Grau, R. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190837 · Cited by 76
“…and present clinical symptoms during their sixth or fifth decade of life (or earlier), and sporadic AD, which is not inherited, but multifactorial [3–5 , 11] and appears The existence of a complete neuronal connectivity map and genetic tractability of C. elegans make this animal model useful for…”
Welcome, M. O. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08547-5 · Cited by 83
A large-scale causal analysis of gut microbiota and delirium: A Mendelian randomization study
Yu, H., Wan, X., Yang, M., Xie, J., Xu, K., Wang, J., Wang, G., & Xu, P. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.078 · Cited by 101
The gut microbiota in neuropsychiatric disorders
Grochowska, M., Wojnar, M., & Radkowski, M. (2018) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2018-008 · Cited by 92
“Bacteria living in the human intestine achieve the high‑ est documented cell concentration for any ecosystem, 1011‑1012 per mL (Hu et al. 2016, Hugenholtz et al. 1998).”
BackgroundGut Microbiota in Neurological Disorders
Grochowska, M., Laskus, T., & Radkowski, M. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00561-6 · Cited by 84
Gabarre, P., Loens, C., Tamzali, Y., Barrou, B., Jaisser, F., & Tourret, J. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16836 · Cited by 85
Is there a relationship between intestinal microbiota, dietary compounds, and obesity?
Kałużna‐Czaplińska, J., Gątarek, P., Chartrand, M. S., Dadar, M., & Bjørklund, G. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.10.010 · Cited by 84
Gadhave, K., Kumar, D., Uversky, V. N., & Giri, R. (2021) · Medicinal Research Reviews · doi:10.1002/med.21719 · Cited by 68
“intervention, diet alterations, and fecal microbiota transplantation were shown to bring modifications in the gut physiology and gut microbiota that increased the risks of AD.(427) Therefore, modulation of the gut microbiome using”
BackgroundThe role of nutrition in Alzheimer’s disease
Śliwińska, S., & Jeziorek, M. (2021) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2021.0154 · Cited by 94
Perioperative neurocognitive dysfunction: thinking from the gut?
Xu, X., Hu, Y., Yan, E., Zhan, G., Liu, C., & Yang, C. (2020) · Aging · doi:10.18632/aging.103738 · Cited by 79
“Senescence-related changes in brain morphology are often seen in a variety of cognitive disorders associated with ageing, such as Alzheimer’s disease [9].”
BackgroundJayatunga, D. P. W., Hone, E., Khaira, H., Lunelli, T., Singh, H., Guillemin, G. J., Fernando, B., Garg, M. L., Verdile, G., & Martins, R. N. (2021) · Nutrients · doi:10.3390/nu13113744 · Cited by 69
“However, it is increasingly being observed that the composition of human gut microbiota is prone to changes in various diseases, including certain types of cancer [145] and also AD [146,147].”
BackgroundSalami, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.613120 · Cited by 67
“Gut Microbiome While the human genome hosts 26,600 genes, the gut microbiota encode about 4,000,000 genes (The Human Microbiome Project and Consortium, 2012; Hu et al., 2016).”
BackgroundInfluentialGut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model
Sun, B.-L., Li, W.-W., Wang, J., Xu, Y.-L., Sun, H.-L., Tian, D.-Y., Wang, Y.-J., & Yao, X.-Q. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181220 · Cited by 66
“Thedyshome-ostasisinthegutmicrobiotaisproposedtobea crucialcauseoftheonsetofAD[11].”
Yadav, S., Dwivedi, A., Tripathi, A., & Tripathi, A. K. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.07.007 · Cited by 67
Wang, Y., Li, Y., Bo, L., Zhou, E., Chen, Y., Naranmandakh, S., Xie, W., Ru, Q., Chen, L., Zhu, Z., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2263207 · Cited by 73
“5 Numerous studies have indicated that intestinal microecology plays an important role in maintaining gut homeostasis in the host and affects the progression of many diseases, 7,12 such as neurodegenerative diseases, 13,14 cardiovascular diseases 15 and metabolic diseases.”
BackgroundFunctional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
Atlante, A., Amadoro, G., Bobba, A., & Latina, V. (2020) · Cells · doi:10.3390/cells9112347 · Cited by 73
Profiling the oral microbiomes in patients with Alzheimer's disease
Guo, H., Li, B., Yao, H., Liu, D., Chen, R., Zhou, S., Ji, Y., Zeng, L., & Du, M. (2021) · Oral Diseases · doi:10.1111/odi.14110 · Cited by 66
Microbiome Influence in the Pathogenesis of Prion and Alzheimer’s Diseases
D’Argenio, V., & Sarnataro, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194704 · Cited by 61
“In addition to the effects on Aβ fibrils, it is important to underline that gut microbiota has also been implicated in some cognitive functions and in memory [102].”
BackgroundHosseini, M., Poljak, A., Braidy, N., Crawford, J. D., & Sachdev, P. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101043 · Cited by 71
Pan, M., Qian, C., Huo, S., Wu, Y., Zhao, X., Ying, Y., Wang, B., Yang, H., Yeerken, A., Wang, T., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2024.2447834 · Cited by 74
“43,44 These results suggest that the collaboration between lactate and A. muciniphila is pivotal in maintaining gut barrier integrity, preventing ecological imbalances, and benefiting the host’s mental health.”
Self-citationImmunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases
Girolamo, F., Coppola, C., & Ribatti, D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.06.017 · Cited by 63
Doulberis, M., Kotronis, G., Gialamprinou, D., Pοlyzos, S. A., Papaefthymiou, A., Katsinelos, P., & Kountouras, J. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1738432 · Cited by 64
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
Zhu, F., Li, C., Chu, F., Tian, X., & Zhu, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.544235 · Cited by 57
“Recently, the studies of several groups have been demonstrated that various diseases, including intestinal diseases and more systemic diseases such as diabetes, metabolic syndrome, and neurodegenerative disorders, including AD and others, are related to the imbalance of gut microbiota called ‘‘dysbiosis’’ (Del Tredici…”
BackgroundAssociation between gut microbiota and psychiatric disorders: a systematic review
Valle, C. G.-D., Fernández, J., Solá, E., Montoya‐Castilla, I., Morillas, C., & Bañuls, C. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1215674 · Cited by 78
“Over the aging period, the organism produces an inflammatory response that can affect the balance of the intestinal microbiota (Hu et al., 2016).”
BackgroundExploring the microbiome in health and disease: Implications for toxicology
Scotti, E., Boué, S., Sasso, G. L., Zanetti, F., Belcastro, V., Poussin, C., Sierro, N., Battey, J. N. D., Gimalac, A., Ivanov, N. V., et al. (2017) · Toxicology Research and Application · doi:10.1177/2397847317741884 · Cited by 97
Alzheimer’s disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?
Arrona Cardoza, P., Spillane, M. B., & Morales Marroquin, E. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab022 · Cited by 53
Zhuang, Z., Gao, M., Yang, R., Liu, Z., Cao, W., & Huang, T. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.10.022 · Cited by 51
Gorlé, N., Blaecher, C., Bauwens, E., Vandendriessche, C., Balusu, S., Vandewalle, J., Van Cauwenberghe, C., Van Wonterghem, E., Van Imschoot, G., Liu, C., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.12.010 · Cited by 49
“…anxiety-like behaviour, autism, Alzheimer’s disease and Parkinson’s disease (Bercik et al., 2011; Bravo et al., 2011; Clapp et al., 2017; Dinan and Cryan, 2017a; Fung et al., 2017; Hu et al., 2016; Kelly et al., 2017; Mulak and Bonaz, 2015; Parracho et al., 2005; Tognini, 2017; Zhang et al., 2015).”
Yan, R., Ho, C., & Zhang, X. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000187 · Cited by 50
Gorlé, N., Bauwens, E., Haesebrouck, F., Smet, A., & Vandenbroucke, R. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584165 · Cited by 56
“risk factor for the development of dementia (21, 49).”
Background
Metadata
- Authors
- Hu, X., Wang, T., & Jin, F.
- Affiliations
- Chinese Academy of Sciences (CN)
- Corresponding author
- Jin, Feng
- Venue
- Science China Life Sciences
- Published
- 2016-08-26
- Volume
- 59
- Issue
- 10
- Pages
- 1006-1023
- ISSN
- 1674-7305 (ISSN-L)
- 1869-1889
- OpenAlex
- W2507288765
- Cited by
- 371
- References
- 196
- Citations by year
- 2026: 17 · 2025: 46 · 2024: 39 · 2023: 49 · 2022: 39 · 2021: 51 · 2020: 37 · 2019: 29 · 2018: 32 · 2017: 29 · 2016: 3
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science China Life Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository of Institute of Psychology, Chinese Academy of Sciences (Institute of Psychology, Chinese Academy of Sciences) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, gut microbiota, microbiota-gut-brain axis, cognitive impairment, germ-free animals, antibiotics, probiotics, diet, intestinal permeability, blood-brain barrier, microbial metabolites, neurodegeneration, hygiene hypothesis, personalized diet, microbiota-based therapy
- MeSH terms
- Gastrointestinal Microbiome, Alzheimer Disease, Animals, Anti-Bacterial Agents, Brain, Cognition, Diet, Humans, Gastrointestinal Tract, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.